BioData World Congress

Interview with the President of the European Institute for Innovation through Health Data

The interview was conducted by the DNAdigest team (dnadigest.org) Dipak Kalra is the President of the European Institute for Innovation through Health Data (i~HD). He is also a Professor of Health Informatics at University College London, and  affiliated with University of Gent. He has worked on the clinical, ethical and legal requirements for electronic health records and on the development of international interoperability standards and will present …

CIRM

Patient Advocate Leads Drive to Add Rare Diseases to CIRM’s Stem Cell Bank

November 1, 2016 Oakland, CA – Christina Waters is a rare kind of person: creative, compassionate, and committed to creating change. Now she is using those rare talents to help children battling rare diseases. She is helping add blood and skin samples from these children to be turned into stem cells and used as a resource for researchers to better understand …

Intel

Intel’s Insights from BioData World Congress 2016

One of our sponsors at BioData World Congress– Intel, prepared a post- event article with insights on the most burning topics that were discussed last week. Last week I was pleased to join a host of partners, customers and industry experts at the leafy Genome Campus in Cambridge, UK, for this year’s BioData World Congress. As one of the world’s leading …

Trials supported by electronic health records

Trials supported by electronic health records – a game-changer for study design and execution Professor Martin Gibson will be revealing the secrets of the successful delivery of GlaxoSmithKline’s (GSK) real world Salford Lung Study at BioData World Congress 2016 on 26 October in Cambridge. Widely recognised as the first study of its kind globally, the Salford Lung Study is a …

DNA Digest

Interview with Head of ELIXIR’s Human Genomics and Translational Data

Our supporting partner DNAdigest got in touch with one of our speakers at BioData World Congress– Serena Scollen, Head of Human Genomics and Translational Data at ELIXIR. Serena will be speaking about maximising opportunities to use human genomics data and about how ELIXIR enables this through European collaborations. We want to share some snippets of the interview and you will be able to access …

HELM

Making Open Source Collaboration Work

Over the past few years the biopharmaceutical industry has deployed an arsenal of increasingly complex biomolecular entities in their search for effective therapeutic agents. Portfolios that were once comprised mainly of small molecules and antibodies have expanded to include modalities like antibody-drug conjugates (ADCs); proteins, peptides and antibodies with synthetic, unnatural amino acids; oligonucleotides with unnatural bases, etc. Investigators at …

HELM

HELM for Antibody Registration

Roche’s Pharmaceutical Research and Early Development (pRED) informatics team has adopted the Pistoia Alliance’s Hierarchical Editing Language for Macromolecules (HELM) as a fundamental building block of their antibody registration tool. As a result, the HELM notation and the HELM Antibody Editor (HAbE) are being rolled out throughout Roche’s bio-therapeutics group (“Large Molecule Research”) to improve the speed, accuracy and effectiveness …

HELM

HELM for Bioregistration

GSK will be making use of the Pistoia Alliance’s Hierarchical Editing Language for Macromolecules (HELM) notation to represent therapeutic large molecules in its bio-registration system, facilitated by the deployment of Dassault Systèmes BIOVIA’s Biological Registration solution. GSK scientists at sites around the world will use the system. Molecular Structure Exchange Across the industry there is a need for an advanced …

Pistoia Alliance

Ontologies Guidelines for Best Practice

By Pistoia Alliance Ontologies Mapping Project team Background These guidelines for best practice support the application and mapping of ontologies in the life sciences as part of the Pistoia Alliance Ontologies Mapping project which creates better tools and services for mapping ontologies to facilitate their exploitation. Ontologies can include hierarchical relationships; taxonomies; classifications and/or vocabularies which are becoming increasingly important for support of …

Pfizer acquisition of cancer drug company could advance oncology research

Published Online: Aug 23,2016 Laurie Toich, Assistant Editor Pfizer recently announced its plans to acquire Medivation, a biopharmaceutical company that develops molecules for oncology. Recent health insurer mergers could have deterred the $14 billion deal, but Pfizer and Medivation’s boards of directors approved the merger, and expect that shares will increase immediately, according to a press release from Pfizer. “The proposed …